Law and Economics of Personalized Medicine Institutional Levers to Foster the Translation of Personalized Medicine /

The book adds to the discussion about strategic approaches towards the translation of personalized medicine into clinical practice. It stresses the importance of non-science related, institutional barriers. A Law and Economics perspective is applied in order to examine the incentives induced by the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Bosshard, Karin (VerfasserIn)
Format: Elektronisch E-Book
Sprache:Englisch
Veröffentlicht: Wiesbaden : Springer Fachmedien Wiesbaden : Gabler, 2018.
Ausgabe:1st ed. 2018.
Schriftenreihe:Gesundheitsmanagement und Gesundheitsökonomik,
Schlagworte:
ISBN:9783658220747
ISSN:2523-7667
Online-Zugang: Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a22000005i 4500
003 SK-BrCVT
005 20220618101147.0
007 cr nn 008mamaa
008 180514s2018 gw | s |||| 0|eng d
020 |a 9783658220747 
024 7 |a 10.1007/978-3-658-22074-7  |2 doi 
035 |a CVTIDW11057 
040 |a Springer-Nature  |b eng  |c CVTISR  |e AACR2 
041 |a eng 
100 1 |a Bosshard, Karin.  |4 aut 
245 1 0 |a Law and Economics of Personalized Medicine  |h [electronic resource] :  |b Institutional Levers to Foster the Translation of Personalized Medicine /  |c by Karin Bosshard. 
250 |a 1st ed. 2018. 
260 1 |a Wiesbaden :  |b Springer Fachmedien Wiesbaden :  |b  Gabler,  |c 2018. 
300 |a XXXVI, 411 p. 41 illus., 7 illus. in color.  |b online resource. 
490 1 |a Gesundheitsmanagement und Gesundheitsökonomik,  |x 2523-7667 
500 |a Economics and Finance  
505 0 |a Overview of terminologies used in the context of personalized medicine -- Description of personalized medicine's impact on the healthcare landscape -- Identification and analysis of the institutional barriers to the translation of personalized medicine into clinical practice -- Analysis of institutional barriers to the translation of personalized medicine in Switzerland -- Identification and evaluation of institutional levers to foster the translation of personalized medicine into Swiss clinical practice. 
516 |a text file PDF 
520 |a The book adds to the discussion about strategic approaches towards the translation of personalized medicine into clinical practice. It stresses the importance of non-science related, institutional barriers. A Law and Economics perspective is applied in order to examine the incentives induced by the barriers. An applied part identifies and evaluates policy levers to foster the translation of personalized medicine into Swiss clinical practice. The content • Overview of terminologies used in the context of personalized medicine • Description of personalized medicine's impact on the healthcare landscape • Identification and analysis of the institutional barriers to the translation of personalized medicine into clinical practice • Analysis of institutional barriers to the translation of personalized medicine in Switzerland • Identification and evaluation of institutional levers to foster the translation of personalized medicine into Swiss clinical practice Target groups • Social scientists with limited knowledge of personalized medicine, Law and Economics scholars, health economists • Practitioners in pharmaceutical, diagnostics and health insurance companies, healthcare policy makers and Swiss lawyers The author Dr. Karin Bosshard wrote this book during her time with a globally leading management consultancy where she was working as a strategy consultant. The author is currently working at an international pharmaceutical and diagnostics company and is a lecturer at the University of St. Gallen. 
650 0 |a Law and economics. 
650 0 |a Evolutionary economics. 
650 0 |a Health economics. 
856 4 0 |u http://hanproxy.cvtisr.sk/han/cvti-ebook-springer-eisbn-978-3-658-22074-7  |y Vzdialený prístup pre registrovaných používateľov 
910 |b ZE08337 
919 |a 978-3-658-22074-7 
974 |a andrea.lebedova  |f Elektronické zdroje 
992 |a SUD 
999 |c 236714  |d 236714